MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
VIR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Vir Biotechnology (VIR) Ownership - Who owns Vir Biotechnology?

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
1800 Owens Street
Phone
+1 415 906-4324
Employees
587
Web
https://www.vir.bio

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.71B
P/E Ratio
N/A
Total Cash
476.3M
Projected Growth
N/A
Total Debt
95.58M
Revenue
64.69M
Risk (Beta)
1.65
Dividend Yield
N/A
Total Cash/Share
2.82
Total Debt/Equity
N/A
Revenue/Share
0.46 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
VIR
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for VIR
A.I. Advisor
published General Information

General Information

a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases

Industry Biotechnology

Profile
Details
Industry
N/A
Address
1800 Owens Street
Phone
+1 415 906-4324
Employees
587
Web
https://www.vir.bio